Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Ectopic expression of Cdk8 induces eccentric hypertrophy and heart failure
Duane D. Hall, Jessica M. Ponce, Biyi Chen, Kathryn M. Spitler, Adrianne Alexia, Gavin Y. Oudit, Long-Sheng Song, Chad E. Grueter
Duane D. Hall, Jessica M. Ponce, Biyi Chen, Kathryn M. Spitler, Adrianne Alexia, Gavin Y. Oudit, Long-Sheng Song, Chad E. Grueter
View: Text | PDF
Research Article Cardiology

Ectopic expression of Cdk8 induces eccentric hypertrophy and heart failure

  • Text
  • PDF
Abstract

Widespread changes in cardiac gene expression occur during heart failure, yet the mechanisms responsible for coordinating these changes remain poorly understood. The Mediator complex represents a nodal point for modulating transcription by bridging chromatin-bound transcription factors with RNA polymerase II activity; it is reversibly regulated by its cyclin-dependent kinase 8 (Cdk8) kinase submodule. Here, we identified increased Cdk8 protein expression in human failing heart explants and determined the consequence of this increase in cardiac-specific Cdk8-expressing mice. Transgenic Cdk8 overexpression resulted in progressive dilated cardiomyopathy, heart failure, and premature lethality. Prior to functional decline, left ventricular cardiomyocytes were dramatically elongated, with disorganized transverse tubules and dysfunctional calcium handling. RNA sequencing results showed that myofilament gene isoforms not typically expressed in adult cardiomyocytes were enriched, while oxidative phosphorylation and fatty acid biosynthesis genes were downregulated. Interestingly, candidate upstream transcription factor expression levels and MAPK signaling pathways thought to determine cardiomyocyte size remained relatively unaffected, suggesting that Cdk8 functions within a novel growth regulatory pathway. Our findings show that manipulating cardiac gene expression through increased Cdk8 levels is detrimental to the heart by establishing a transcriptional program that induces pathological remodeling and eccentric hypertrophy culminating in heart failure.

Authors

Duane D. Hall, Jessica M. Ponce, Biyi Chen, Kathryn M. Spitler, Adrianne Alexia, Gavin Y. Oudit, Long-Sheng Song, Chad E. Grueter

×

Figure 6

RNA analysis indicates that cardiac-specific Cdk8 expression promotes myofilament isoform switching and downregulation of mitochondrial-related metabolic pathways.

Options: View larger image (or click on image) Download as PowerPoint
RNA analysis indicates that cardiac-specific Cdk8 expression promotes my...
(A) Scatter plot of RNA sequencing (RNA-seq) expression values of significant differentially regulated ventricular RNAs (false discovery rate < 0.05) with greater than 5 fragments per kilobase per million reads (FPKM) from 3-week-old WT and Tg8a littermates (n = 5). An additional cutoff of 1.5-fold upregulated and downregulated genes is marked by dashed lines (red, upregulated >1.5-fold; light red, upregulated <1.5-fold; light blue, downregulated <1.5-fold; blue, downregulated >1.5-fold). Select myofilament and metabolic genes are designated. (B) Top 10 hits from KEGG pathway enrichment analyses of RNA-seq results. Significantly upregulated (red) and downregulated (blue) gene sets >1.5-fold change) were analyzed separately via the WebGestalt online tool. “Metabolic pathways” is the only top 10 category enriched in both sets. (C) Top predicted annotations for diseases and functions ranked by Z-score by Ingenuity Pathway Analysis (IPA) for all significant differentially expressed genes (>1.5-fold up/downregulated). (D and E) Quantitative reverse transcriptase PCR of differentially expressed sarcomeric (D) and metabolic (E) genes identified by RNA-seq analysis. Changes in expression were validated in independent 3-week-old (filled symbols) WT (gray), Tg8a (magenta), and Tg8b (cyan) ventricular samples and compared with 15-week-old (white symbols) WT and failing Tg8a hearts. *P < 0.05 vs. 3-week WT; §P < 0.05 3-week vs. 15-week Tg8a; ‡P < 0.05 15-week WT vs. 15-week Tg8a; 1-way ANOVA with Tukey’s multiple comparisons test; n = 3–4 performed in triplicate. Dashed magenta line represents the fold change (Tg8a vs. WT) from RNA-seq results.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts